Skip to main content

Table 1 Demographics and tumor characteristics

From: A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

Characteristics (n = 74) No. of patients (%)
Age, median years (range) 61 (21-79)
Primary site
  Ovary 69 (93)
  Peritoneal 2 (3)
  Fallopian tube 3 (4)
Original stage
  Ic 5 (7)
  IIb 1 (1)
  IIc 5 (7)
  IIIa 4 (5)
  IIIb 5 (7)
  IIIc 45 (61)
  IV 8 (11)
  Unknown 1 (1)
Tumor grade
  Well differentiate 11 (15)
  Moderate well differentiate 21 (28)
  Poorly differentiate/undifferentiate 36 (49)
  Unknown 6 (8)
Histologic type
  Serous 60 (81)
  Mucinous 2 (3)
  Clear cell 2 (3)
  Endometroid 5 (7)
  Undifferentiate 1 (1)
  Other 4 (5)
Response to firs line therapy
  Complete response (CR) 38 (51)
  Partial response (PR) 8 (11)
  Stable disease (SD) 2 (3)
  Non-evaluated disease (NED) 26 (35)
Time from end of first line chemotherapy to relapse
  Median months (range) 15.7 (6-80.9)
  Relapse between 6 to 12 months 26 (35.1%)
  Relapse >12 months 48 (64.9%)